
Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases
Author(s) -
Zuohong Ma,
Yongpeng Wang,
Zheng Wei,
Jun Ma,
Xue Bai,
Yong Zhang,
Yuanhe Wang,
Da Chi,
Xibo Fu,
Xiangdong Hua
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i10.1177
Subject(s) - medicine , colorectal cancer , proportional hazards model , hepatectomy , cancer , oncology , chemotherapy , liver cancer , survival analysis , multivariate analysis , surgery , gastroenterology , resection
Colorectal cancer (CRC) is one of the most common malignant tumors in China, and the liver is the most common metastatic site in patients with advanced CRC. Hepatectomy is the gold standard treatment for colorectal liver metastases. For patients who cannot undergo radical resection of liver metastases for various reasons, ablation therapy, interventional therapy, and systemic chemotherapy can be used to improve their quality of life and prolong their survival time.